|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.04 USD | -1.18% |
|
+11.01% | -35.30% |
| Apr. 09 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
| Apr. 09 | Syros Gets Fast Track Label For Tamibarotene to Treat Acute Myeloid Leukemia; Shares Rise | MT |
Syros Pharmaceuticals, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 0.387 million compared to negative sales of USD 0.754 million a year ago. Net loss was USD 64.38 million compared to USD 4.77 million a year ago.
Basic loss per share from continuing operations was USD 2.18.
| 1st Jan change | Capi. | |
|---|---|---|
| -35.30% | 135M | |
| +1.51% | 42.75B | |
| +8.57% | 41.34B | |
| +49.22% | 41.61B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
SYROS PHARMACEUTICALS, INC. 
